Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 257

1.

Oral Dimethyl Fumarate Reduces Peripheral Neuropathic Pain in Rodents via NFE2L2 Antioxidant Signaling.

Li J, Ma J, Lacagnina MJ, Lorca S, Odem MA, Walters ET, Kavelaars A, Grace PM.

Anesthesiology. 2020 Feb;132(2):343-356. doi: 10.1097/ALN.0000000000003077.

PMID:
31939850
2.

GRK2 levels in myeloid cells modulate adipose-liver crosstalk in high fat diet-induced obesity.

Vila-Bedmar R, Cruces-Sande M, Arcones AC, Willemen HLDM, Prieto P, Moreno-Indias I, Díaz-Rodríguez D, Francisco S, Jaén RI, Gutiérrez-Repiso C, Heijnen CJ, Boscá L, Fresno M, Kavelaars A, Mayor F Jr, Murga C.

Cell Mol Life Sci. 2020 Jan 11. doi: 10.1007/s00018-019-03442-5. [Epub ahead of print]

PMID:
31927610
3.

Oral Dimethyl Fumarate Reduces Peripheral Neuropathic Pain in Rodents via NFE2L2 Antioxidant Signaling.

Li J, Ma J, Lacagnina MJ, Lorca S, Odem MA, Walters ET, Kavelaars A, Grace PM.

Anesthesiology. 2019 Dec 5. doi: 10.1097/ALN.0000000000003077. [Epub ahead of print]

PMID:
31841447
4.

Alleviation of paclitaxel-induced mechanical hypersensitivity and hyperalgesic priming with AMPK activators in male and female mice.

Inyang KE, McDougal TA, Ramirez ED, Williams M, Laumet G, Kavelaars A, Heijnen CJ, Burton M, Dussor G, Price TJ.

Neurobiol Pain. 2019 Sep 27;6:100037. doi: 10.1016/j.ynpai.2019.100037. eCollection 2019 Aug-Dec.

5.

T Cells as an Emerging Target for Chronic Pain Therapy.

Laumet G, Ma J, Robison AJ, Kumari S, Heijnen CJ, Kavelaars A.

Front Mol Neurosci. 2019 Sep 11;12:216. doi: 10.3389/fnmol.2019.00216. eCollection 2019.

6.

Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers.

Ma J, Trinh RT, Mahant ID, Peng B, Matthias P, Heijnen CJ, Kavelaars A.

Pain. 2019 Dec;160(12):2877-2890. doi: 10.1097/j.pain.0000000000001667.

PMID:
31356453
7.

Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment.

Chiang ACA, Huo X, Kavelaars A, Heijnen CJ.

Brain Behav Immun. 2019 Jul;79:319-325. doi: 10.1016/j.bbi.2019.04.005. Epub 2019 Apr 3.

8.

Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice.

Laumet G, Edralin JD, Dantzer R, Heijnen CJ, Kavelaars A.

Pain. 2019 Jun;160(6):1459-1468. doi: 10.1097/j.pain.0000000000001512.

PMID:
30720585
9.

Mitochondrial transfer from mesenchymal stem cells to neural stem cells protects against the neurotoxic effects of cisplatin.

Boukelmoune N, Chiu GS, Kavelaars A, Heijnen CJ.

Acta Neuropathol Commun. 2018 Dec 12;6(1):139. doi: 10.1186/s40478-018-0644-8.

10.

Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice.

Huo X, Reyes TM, Heijnen CJ, Kavelaars A.

Sci Rep. 2018 Nov 27;8(1):17400. doi: 10.1038/s41598-018-35919-x.

11.

Nasal administration of mesenchymal stem cells restores cisplatin-induced cognitive impairment and brain damage in mice.

Chiu GS, Boukelmoune N, Chiang ACA, Peng B, Rao V, Kingsley C, Liu HL, Kavelaars A, Kesler SR, Heijnen CJ.

Oncotarget. 2018 Oct 30;9(85):35581-35597. doi: 10.18632/oncotarget.26272. eCollection 2018 Oct 30.

12.

Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.

Ma J, Huo X, Jarpe MB, Kavelaars A, Heijnen CJ.

Acta Neuropathol Commun. 2018 Oct 1;6(1):103. doi: 10.1186/s40478-018-0604-3.

13.

Patient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia.

Lacourt TE, Kavelaars A, Ohanian M, Shah ND, Shelburne SA, Futreal A, Kontoyiannis DP, Heijnen CJ.

Oncotarget. 2018 Jul 27;9(58):31244-31252. doi: 10.18632/oncotarget.25787. eCollection 2018 Jul 27.

14.

Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling.

Laumet G, Edralin JD, Chiang AC, Dantzer R, Heijnen CJ, Kavelaars A.

Neuropsychopharmacology. 2018 Dec;43(13):2597-2605. doi: 10.1038/s41386-018-0154-1. Epub 2018 Jul 16.

15.

Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor.

Wang HJ, Gu HX, Eijkelkamp N, Heijnen CJ, Kavelaars A.

Front Pharmacol. 2018 Jun 5;9:592. doi: 10.3389/fphar.2018.00592. eCollection 2018.

16.

Transition to chronic pain: opportunities for novel therapeutics.

Price TJ, Basbaum AI, Bresnahan J, Chambers JF, De Koninck Y, Edwards RR, Ji RR, Katz J, Kavelaars A, Levine JD, Porter L, Schechter N, Sluka KA, Terman GW, Wager TD, Yaksh TL, Dworkin RH.

Nat Rev Neurosci. 2018 Jul;19(7):383-384. doi: 10.1038/s41583-018-0012-5. No abstract available.

17.

Motivational changes that develop in a mouse model of inflammation-induced depression are independent of indoleamine 2,3 dioxygenase.

Vichaya EG, Laumet G, Christian DL, Grossberg AJ, Estrada DJ, Heijnen CJ, Kavelaars A, Dantzer R.

Neuropsychopharmacology. 2019 Jan;44(2):364-371. doi: 10.1038/s41386-018-0075-z. Epub 2018 Apr 27.

18.

Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.

Ma J, Kavelaars A, Dougherty PM, Heijnen CJ.

Cancer. 2018 Jun 1;124(11):2289-2298. doi: 10.1002/cncr.31248. Epub 2018 Feb 20. Review.

19.

Identification of FAM173B as a protein methyltransferase promoting chronic pain.

Willemen HLDM, Kavelaars A, Prado J, Maas M, Versteeg S, Nellissen LJJ, Tromp J, Gonzalez Cano R, Zhou W, Jakobsson ME, Małecki J, Posthuma G, Habib AM, Heijnen CJ, Falnes PØ, Eijkelkamp N.

PLoS Biol. 2018 Feb 14;16(2):e2003452. doi: 10.1371/journal.pbio.2003452. eCollection 2018 Feb.

20.

Associations of inflammation with symptom burden in patients with acute myeloid leukemia.

Lacourt TE, Kavelaars A, Galloway-Peña JR, Sahasrabhojane PV, Shah ND, Futreal A, Kontoyiannis DP, Shelburne SA, Heijnen CJ.

Psychoneuroendocrinology. 2018 Mar;89:203-208. doi: 10.1016/j.psyneuen.2018.01.018.

PMID:
29414033

Supplemental Content

Loading ...
Support Center